JavaScript is NOT enabled !

Burdett P, Lip GYH. Atrial fibrillation in the United Kingdom: predicting costs of an emerging epidemic recognising and forecasting the cost drivers of atrial fibrillation-related costs. Eur Heart J Qual Care Clin Outcomes 2020;8:187–94. PubMed

Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129:837–47. PubMed PMC

Wang L, Ze F, Li J, Mi L, Han B, Niu H et al. Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017. Heart 2021;107:881–7. PubMed

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014;6:213–20. PubMed PMC

Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–52. PubMed

Lip G, Freedman B, De Caterina R, Potpara TS. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making. Thromb Haemost 2017;117:1230–9. PubMed

Yoon M, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS et al. Improved population-based clinical outcomes of patients with atrial fibrillation by compliance with the simple ABC (atrial fibrillation better care) pathway for integrated care management: a Nationwide Cohort Study. Thromb Haemost 2019;119:1695–703. PubMed

Romiti GF, Pastori D, Rivera-Caravaca JM, Ding WY, Gue YX, Menichelli D et al. Adherence to the ‘atrial fibrillation better care’ pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost 2022;122:406–14. PubMed

Lip GYH. The ABC pathway: an integrated approach to improve AF management. Nat Rev Cardiol 2017;14:627–8. PubMed

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2021;42:373–498. PubMed

Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost 2022;122:20–47. PubMed PMC

Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J et al. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014;370:2467–77. PubMed

Svendsen JH, Diederichsen SZ, Højberg S, Krieger DW, Graff C, Kronborg C et al. Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP study): a randomised controlled trial. Lancet 2021;398:1507–16. PubMed

Wallenhorst C, Martinez C, Freedman B. Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations. Thromb Haemost 2022;122:277–85. PubMed

Proietti M, Boriani G. Screening for atrial fibrillation in relation to stroke and mortality risk. Thromb Haemost 2021. doi:10.1055/s-0041-1735189. PubMed DOI

Steinberg JS, O’Connell H, Li S, Ziegler PD. Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database. Circ Arrhythm Electrophysiol 2018;11:e006274. PubMed

Kaufman ES, Israel CW, Nair GM, Armaganijan L, Divakaramenon S, Mairesse GH et al. Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: an analysis from ASSERT. Heart Rhythm 2012;9:1241–6. PubMed

Potpara TS, Lip GYH, Blomstrom-Lundqvist C, Boriani G, Van Gelder IC, Heidbuchel H et al. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to In-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost 2021;121:270–8. PubMed

Lubitz SA, Faranesh AZ, Atlas SJ, McManus DD, Singer DE, Pagoto S et al. Rationale and design of a large population study to validate software for the assessment of atrial fibrillation from data acquired by a consumer tracker or smartwatch: the Fitbit heart study. Am Heart J 2021;238:16–26. PubMed

Lopes RD, Alings M, Connolly SJ, Beresh H, Granger CB, Mazuecos JB et al. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial. Am Heart J 2017;189:137–45. PubMed

Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC et al. Probing oral anticoagulation in patients with atrial high rate episodes: rationale and design of the non-vitamin K antagonist oral anticoagulants in patients with atrial high rate episodes (NOAH-AFNET 6) trial. Am Heart J 2017;190:12–8. PubMed PMC

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:e199–267. PubMed PMC

Ghazal F, Theobald H, Rosenqvist M, Al-Khalili F. Validity of daily self-pulse palpation for atrial fibrillation screening in patients 65 years and older: a cross-sectional study. PLoS Med 2020;17:e1003063. PubMed PMC

Clark CE, McDonagh STJ, McManus RJ. Accuracy of automated blood pressure measurements in the presence of atrial fibrillation: systematic review and meta-analysis. J Hum Hypertens 2019;33:352–64. PubMed

Kyriakoulis KG, Kollias A, Anagnostopoulos I, Gravvani A, Kalogeropoulos P, Destounis A et al. Diagnostic accuracy of a novel cuffless self-blood pressure monitor for atrial fibrillation screening in the elderly. J Clin Hypertens (Greenwich) 2019;21:1797–802. PubMed PMC

Perez MV, Mahaffey KW, Hedlin H, Rumsfeld JS, Garcia A, Ferris T et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019;381:1909–17. PubMed PMC

Guo Y, Wang H, Zhang H, Chen Y, Lip GYH. Population-based screening or targeted screening based on initial clinical risk assessment for atrial fibrillation: a report from the Huawei heart study. J Clin Med 2020;9:1493. PubMed PMC

Rajakariar K, Koshy AN, Sajeev JK, Nair S, Roberts L, Teh AW. Accuracy of a smartwatch based single-lead electrocardiogram device in detection of atrial fibrillation. Heart 2020;106:665–70. PubMed

Steinhubl SR, Waalen J, Edwards AM, Ariniello LM, Mehta RR, Ebner GS et al. Effect of a home-based wearable continuous ECG monitoring patch on detection of undiagnosed atrial fibrillation: the mSToPS randomized clinical trial. JAMA 2018;320:146–55. PubMed PMC

Lumikari TJ, Pirinen J, Putaala J, Sibolt G, Kerola A, Pakarinen S et al. Prolonged ECG with a novel recorder utilizing electrode belt and mobile device in patients with recent embolic stroke of undetermined source: a pilot study. Ann Noninvasive Electrocardiol 2020;25:e12802. PubMed PMC

Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA et al. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478–86. PubMed

Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 2015;131:2176–84. PubMed

Svennberg E, Friberg L, Frykman V, Al-Khalili F, Engdahl J, Rosenqvist M. Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet 2021;398:1498–506. PubMed

Doliwa Sobocinski P, Anggårdh Rooth E, Frykman Kull V, von Arbin M, Wallén H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012;14:1112–6. PubMed

Miyazawa K, Mairesse GH, Lip GYH. Screening for atrial fibrillation: look harder, look longer, and improve stroke outcomes with oral anticoagulation. Europace 2018;20:f278–9. PubMed

Gladstone DJ, Dorian P, Spring M, Panzov V, Mamdani M, Healey JS et al. Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the EMBRACE trial. Stroke 2015;46:936–41. PubMed

Chong BH, Pong V, Lam KF, Liu S, Zuo ML, Lau YF et al. Frequent premature atrial complexes predict new occurrence of atrial fibrillation and adverse cardiovascular events. Europace 2012;14:942–7. PubMed

Olsen FJ, Møgelvang R, Jensen GB, Jensen JS, Biering-Sørensen T. Relationship between left atrial functional measures and incident atrial fibrillation in the general population: the Copenhagen city heart study. JACC Cardiovasc Imaging 2019;12:981–9. PubMed

Benjamin EJ, Go AS, Desvigne-Nickens P, Anderson CD, Casadei B, Chen LY et al. Research priorities in atrial fibrillation screening: a report from a national heart, lung, and blood institute virtual workshop. Circulation 2021;143:372–88. PubMed PMC

Schnabel RB, Sullivan LM, Levy D, Pencina MJ, Massaro JM, D’Agostino RB Sr, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373:739–45. PubMed PMC

Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc 2013;2:e000102. PubMed PMC

Everett BM, Cook NR, Conen D, Chasman DI, Ridker PM, Albert CM. Novel genetic markers improve measures of atrial fibrillation risk prediction. Eur Heart J 2013;34:2243–51. PubMed PMC

Aronson D, Shalev V, Katz R, Chodick G, Mutlak D. Risk score for prediction of 10-year atrial fibrillation: a community-based study. Thromb Haemost 2018;118:1556–63. PubMed

Hamada R, Muto S. Simple risk model and score for predicting of incident atrial fibrillation in Japanese. J Cardiol 2019;73:65–72. PubMed

Li YG, Pastori D, Farcomeni A, Yang PS, Jang E, Joung B et al. A simple clinical risk score (C(2)HEST) for predicting incident atrial fibrillation in Asian subjects: derivation in 471,446 Chinese subjects, with internal validation and external application in 451,199 Korean subjects. Chest 2019;155:510–8. PubMed PMC

Lip GYH, Skjøth F, Nielsen PB, Larsen TB. Evaluation of the C(2)HEST risk score as a possible opportunistic screening tool for incident atrial fibrillation in a healthy population (from a Nationwide Danish Cohort Study). Am J Cardiol 2020;125:48–54. PubMed

Li YG, Bisson A, Bodin A, Herbert J, Grammatico-Guillon L, Joung B et al. C(2) HEST score and prediction of incident atrial fibrillation in poststroke patients: a French nationwide study. J Am Heart Assoc 2019;8:e012546. PubMed PMC

Li YG, Pastori D, Miyazawa K, Shahid F, Lip GYH. Identifying at-risk patients for sustained atrial high-rate episodes using the C(2)HEST score: the west Birmingham atrial fibrillation project. J Am Heart Assoc 2021;10:e017519. PubMed PMC

Mitrega K, Lip GYH, Sredniawa B, Sokal A, Streb W, Przyludzki K et al. Predicting silent atrial fibrillation in the elderly: a report from the NOMED-AF cross-sectional study. J Clin Med 2021;10:2321. PubMed PMC

Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol 2004;43:47–52. PubMed

Brachmann J, Morillo CA, Sanna T, Di Lazzaro V, Diener HC, Bernstein RA et al. Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial. Circ Arrhythm Electrophysiol 2016;9:e003333. PubMed

Ritter MA, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG et al. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 2013;44:1449–52. PubMed

Kishore A, Vail A, Majid A, Dawson J, Lees KR, Tyrrell PJ et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke 2014;45:520–6. PubMed

Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism. Intern Med J 2004;34:305–9. PubMed

Kemp Gudmundsdottir K, Fredriksson T, Svennberg E, Al-Khalili F, Friberg L, Frykman V et al. Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study. Europace 2020;22:24–32. PubMed PMC

Guo Y, Wang H, Zhang H, Liu T, Liang Z, Xia Y et al. Mobile photoplethysmographic technology to detect atrial fibrillation. J Am Coll Cardiol 2019;74:2365–75. PubMed

Turakhia MP, Desai M, Hedlin H, Rajmane A, Talati N, Ferris T et al. Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: the Apple heart study. Am Heart J 2019;207:66–75. PubMed PMC

Brasier N, Raichle CJ, Dörr M, Becke A, Nohturfft V, Weber S et al. Detection of atrial fibrillation with a smartphone camera: first prospective, international, two-centre, clinical validation study (DETECT AF PRO). Europace 2019;21:41–7. PubMed PMC

Yan BP, Lai WHS, Chan CKY, Chan SC, Chan LH, Lam KM et al. Contact-free screening of atrial fibrillation by a smartphone using facial pulsatile photoplethysmographic signals. J Am Heart Assoc 2018;7:e008585. PubMed PMC

Lewis M, Parker D, Weston C, Bowes M. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br J Gen Pract 2011;61:38–9. PubMed PMC

Chan PH, Wong CK, Poh YC, Pun L, Leung WW, Wong YF et al. Diagnostic performance of a smartphone-based photoplethysmographic application for atrial fibrillation screening in a primary care setting. J Am Heart Assoc 2016;5:e003428. PubMed PMC

McManus MD, Chong JW, Soni A, Saczynski JS, Esa N, Napolitano C et al. PULSE-SMART: pulse-based arrhythmia discrimination using a novel smartphone application. J Cardiovasc Electrophysiol 2016;27:51–7. PubMed PMC

Eerikäinen LM, Bonomi AG, Schipper F, Dekker LRC, Vullings R, de Morree HM et al. Comparison between electrocardiogram- and photoplethysmogram-derived features for atrial fibrillation detection in free-living conditions. Physiol Meas 2018;39:084001. PubMed

Verbrugge FH, Proesmans T, Vijgen J, Mullens W, Rivero-Ayerza M, Van Herendael H et al. Atrial fibrillation screening with photo-plethysmography through a smartphone camera. Europace 2019;21:1167–75. PubMed

Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120–9. PubMed

Pluymaekers N, Hermans ANL, van der Velden RMJ, Gawałko M, den Uijl DW, Buskes S et al. Implementation of an on-demand app-based heart rate and rhythm monitoring infrastructure for the management of atrial fibrillation through teleconsultation: TeleCheck-AF. Europace 2021;23:345–52. PubMed PMC

Steinberg JS, Varma N, Cygankiewicz I, Aziz P, Balsam P, Baranchuk A et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Heart Rhythm 2017;14:e55–96. PubMed

Rubio Campal JM, García Torres MA, Sánchez Borque P, Navas Vinagre I, Zamarbide Capdepón I, Miracle Blanco Á et al. Detecting atrial fibrillation in patients with an embolic stroke of undetermined source (from the DAF-ESUS registry). Am J Cardiol 2020;125:409–14. PubMed

Pagola J, Juega J, Francisco-Pascual J, Moya A, Sanchis M, Bustamante A et al. Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: pilot study of Crypto-AF registry. Int J Cardiol 2018;251:45–50. PubMed

Wachter R, Gröschel K, Gelbrich G, Hamann GF, Kermer P, Liman J et al. Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF(RANDOMISED)): an open-label randomised controlled trial. Lancet Neurol 2017;16:282–90. PubMed

Hariri E, Hachem A, Sarkis G, Nasr S. Optimal duration of monitoring for atrial fibrillation in cryptogenic stroke: a nonsystematic review. Biomed Res Int 2016;2016:5704963. PubMed PMC

Schnabel RB, Haeusler KG, Healey JS, Freedman B, Boriani G, Brachmann J et al. Searching for atrial fibrillation poststroke: a white paper of the AF-SCREEN International Collaboration. Circulation 2019;140:1834–50. PubMed

Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med 2014;127:95.e11–7. PubMed PMC

Gladstone DJ, Wachter R, Schmalstieg-Bahr K, Quinn FR, Hummers E, Ivers N et al. Screening for atrial fibrillation in the older population: a randomized clinical trial. JAMA Cardiol 2021;6:558–67. PubMed PMC

Van Gelder IC, Healey JS, Crijns H, Wang J, Hohnloser SH, Gold MR et al. Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 2017;38:1339–44. PubMed

Friberg L, Rosenqvist M, Lip GY. Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation 2012;125:2298–307. PubMed

Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ et al. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol 2014;13:429–38. PubMed

Kapa S, Epstein AE, Callans DJ, Garcia FC, Lin D, Bala R et al. Assessing arrhythmia burden after catheter ablation of atrial fibrillation using an implantable loop recorder: the ABACUS study. J Cardiovasc Electrophysiol 2013;24:875–81. PubMed

Boriani G, Glotzer TV, Santini M, West TM, De Melis M, Sepsi M et al. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices). Eur Heart J 2014;35:508–16. PubMed PMC

Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J et al. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace 2017;19:1589–623. PubMed

Gorenek BC, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV et al. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2017;19:1556–78. PubMed

Freedman B, Boriani G, Glotzer TV, Healey JS, Kirchhof P, Potpara TS. Management of atrial high-rate episodes detected by cardiac implanted electronic devices. Nat Rev Cardiol 2017;14:701–14. PubMed

Mahajan R, Perera T, Elliott AD, Twomey DJ, Kumar S, Munwar DA et al. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J 2018;39:1407–15. PubMed

Vitolo M, Imberti JF, Maisano A, Albini A, Bonini N, Valenti AC et al. Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis. Eur J Intern Med 2021;92:100–6. PubMed

Boriani G, Pettorelli D. Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation. Vascul Pharmacol 2016;83:26–35. PubMed

Boriani G, Glotzer TV, Ziegler PD, De Melis M, Mangoni di SSL, Sepsi M et al. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden. Heart Rhythm 2018;15:376–83. PubMed

Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest 2018;154:1121–201. PubMed

Hill NR, Ayoubkhani D, McEwan P, Sugrue DM, Farooqui U, Lister S et al. Predicting atrial fibrillation in primary care using machine learning. PLoS One 2019;14:e0224582. PubMed PMC

Lip GYH, Genaidy A, Tran G, Marroquin P, Estes C, Sloop S. Improving stroke risk prediction in the general population: a comparative assessment of common clinical rules, a new multimorbid index, and machine-learning-based algorithms. Thromb Haemost 2022;122:142–50. PubMed

Lip GYH, Tran G, Genaidy A, Marroquin P, Estes C. Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: a machine-learning approach. J Arrhythm 2021;37:931–41. PubMed PMC

Attia ZI, Noseworthy PA, Lopez-Jimenez F, Asirvatham SJ, Deshmukh AJ, Gersh BJ et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm: a retrospective analysis of outcome prediction. Lancet 2019;394:861–7. PubMed

Newest 20 citations...

See more in
Medvik | PubMed

PULSE survey: Population Survey on Knowledge, Gaps and Perception of Heart Rhythm disorders-an initiative of the Scientific Initiatives Committee of the European Heart Rhythm Association

Europace. 2025 Mar 28 ; 27 (4) : .

ISSN 1532-2092 | 1099-5129
Source

Borrow
RIS

Find record

In BMC

Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper

Find record

Citation metrics

Archiving options